Physician profile
Danielle M Stone
NPI 1710371612
$5,764.65
in general payments reported to CMS, 2019-2025
19 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $372 · 2021: $1,525 · 2022: $2,540 · 2023: $101 · 2024: $374 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,694.25 | 2021-2022 | |
| Abbott Laboratories | $852.90 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $294.01 | 2020-2025 | Camzyos |
| Shockwave Medical, INC | $293.48 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $239.87 | 2019-2025 | Farxiga |
| Astellas Pharma US INC | $198.00 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $196.58 | 2021-2025 | Lifevest |
| Heartflow, INC. | $172.07 | 2025 | |
| Novo Nordisk INC | $148.47 | 2025 | Wegovy |
| Canon Medical Systems USA, INC. | $133.05 | 2024 | General Device(S) |
| Medline Industries LP | $127.52 | 2024-2025 | |
| Inari Medical, INC. | $124.17 | 2021 | |
| Boston Scientific Corporation | $88.24 | 2020 | |
| Amgen INC. | $78.89 | 2019-2025 | Repatha, Repatha |
| Abiomed | $41.20 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $33.12 | 2025 | Nimbl, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $17.15 | 2024 | |
| Acist Medical Systems, INC. | $16.87 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.81 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.